Micro Emerging Active

SYNH hissesi $8M satışıyla %72 arttı, Kynam Capital hissesini azalttı

Puan
0,3
Hız
▲ 0,0
Makaleler
3
Kaynaklar
1

Özet

Bir makale, Syndax Pharmaceuticals'ın kurumsal yatırımlarındaki değişiklikleri tartışıyorsa bu anlatıya aittir.

İlgili Makaleler

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

Nasdaq · Mar 22, 2026
Mixed

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a …

Nasdaq · Mar 22, 2026
Mixed

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems …

Nasdaq · Mar 21, 2026
Neutral

Kaynaklar

Structure Therapeutics Slides 28% This Year as $6 Million Stake … Nasdaq
This $116 Million Buy Joins a 360% Stock Run and … Nasdaq
Biotech Stock Up 72% Sees $8 Million Sale, but Here's … Nasdaq

Zaman Çizelgesi

Son Güncelleme Mar 21, 2026